{"id":"https://openalex.org/W2087782827","doi":"https://doi.org/10.1007/bf02244927","title":"Effects of antipsychotic drugs on latent inhibition: sensitivity and specificity of an animal behavioral model of clinical drug action","display_name":"Effects of antipsychotic drugs on latent inhibition: sensitivity and specificity of an animal behavioral model of clinical drug action","alternate_titles":[],"publication_year":1993,"publication_date":"1993-09-01","ids":{"openalex":"https://openalex.org/W2087782827","doi":"https://doi.org/10.1007/bf02244927","mag":"2087782827","pmid":"https://pubmed.ncbi.nlm.nih.gov/7871036"},"language":"en","primary_location":{"id":"doi:10.1007/bf02244927","doi":"https://doi.org/10.1007/bf02244927","is_oa":false,"landing_page_url":"https://doi.org/10.1007/bf02244927","pdf_url":null,"source":{"id":"https://openalex.org/S80334769","display_name":"Psychopharmacology","issn_l":"0033-3158","issn":["0033-3158","1432-2072"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2087782827"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110154942","display_name":"Lawrence A. Dunn","orcid":"https://orcid.org/0009-0000-6541-2354","observed_orcids":["https://orcid.org/0009-0000-6541-2354"]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lawrence A. Dunn","raw_affiliation_strings":["Department of Psychiatry, Duke University Medical Center, Durham, NC 27710","Department of Psychiatry, Duke University Medical Center, Box 3400, 27710, Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Duke University Medical Center, Durham, NC 27710","institution_ids":["https://openalex.org/I4210126298"]},{"raw_affiliation_string":"Department of Psychiatry, Duke University Medical Center, Box 3400, 27710, Durham, NC, USA","institution_ids":["https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062554518","display_name":"Gail E. Atwater","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gail E. Atwater","raw_affiliation_strings":["Department of Psychiatry, Duke University Medical Center, Durham, USA","Department of Psychiatry, Duke University Medical Center, Box 3400, 27710, Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Duke University Medical Center, Durham, USA","institution_ids":["https://openalex.org/I4210126298"]},{"raw_affiliation_string":"Department of Psychiatry, Duke University Medical Center, Box 3400, 27710, Durham, NC, USA","institution_ids":["https://openalex.org/I4210126298"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5067317275","display_name":"Clinton D. Kilts","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Clinton D. Kilts","raw_affiliation_strings":["Department of Psychiatry, Emory University School of Medicine, Atlanta, USA","Department of Psychiatry, Emory University School of Medicine, 30322, Atlanta, GA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Emory University School of Medicine, Atlanta, USA","institution_ids":["https://openalex.org/I150468666"]},{"raw_affiliation_string":"Department of Psychiatry, Emory University School of Medicine, 30322, Atlanta, GA, USA","institution_ids":["https://openalex.org/I150468666"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":null,"fwci":14.5761,"has_fulltext":false,"cited_by_count":178,"citation_normalized_percentile":{"value":0.9937578,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"112","issue":"2-3","first_page":"315","last_page":"323"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/latent-inhibition","display_name":"latent inhibition","score":0.9959999918937683},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.9559999704360962},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.8450000286102295},{"id":"https://openalex.org/keywords/haloperidol","display_name":"haloperidol","score":0.8880000114440918},{"id":"https://openalex.org/keywords/conditioned-emotional-response","display_name":"conditioned emotional response","score":0.9440000057220459},{"id":"https://openalex.org/keywords/selective-attention","display_name":"selective attention","score":0.8610000014305115},{"id":"https://openalex.org/keywords/animal-models-of-schizophrenia","display_name":"animal models of schizophrenia","score":0.5820000171661377},{"id":"https://openalex.org/keywords/trihexyphenidyl","display_name":"trihexyphenidyl","score":0.8759999871253967},{"id":"https://openalex.org/keywords/anticholinergic-drugs","display_name":"anticholinergic agents","score":0.7379999756813049},{"id":"https://openalex.org/keywords/fluphenazine","display_name":"fluphenazine","score":0.8100000023841858},{"id":"https://openalex.org/keywords/chlorpromazine","display_name":"chlorpromazine","score":0.9950000047683716},{"id":"https://openalex.org/keywords/thiothixene","display_name":"thiothixene","score":0.8730000257492065},{"id":"https://openalex.org/keywords/thioridazine","display_name":"thioridazine","score":0.9940000176429749},{"id":"https://openalex.org/keywords/mesoridazine","display_name":"mesoridazine","score":0.9739999771118164},{"id":"https://openalex.org/keywords/metoclopramide","display_name":"metoclopramide","score":0.9940000176429749},{"id":"https://openalex.org/keywords/clozapine","display_name":"clozapine","score":0.9129999876022339},{"id":"https://openalex.org/keywords/pentobarbital","display_name":"pentobarbital","score":0.7720000147819519},{"id":"https://openalex.org/keywords/imipramine","display_name":"imipramine","score":0.9940000176429749},{"id":"https://openalex.org/keywords/chlordiazepoxide","display_name":"chlordiazepoxide","score":0.9959999918937683},{"id":"https://openalex.org/keywords/promethazine","display_name":"promethazine","score":0.906000018119812},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.4860000014305115}],"concepts":[{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.8061041235923767},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7678770422935486},{"id":"https://openalex.org/C2778775820","wikidata":"https://www.wikidata.org/wiki/Q407972","display_name":"Chlorpromazine","level":2,"score":0.744844913482666},{"id":"https://openalex.org/C2780864610","wikidata":"https://www.wikidata.org/wiki/Q221361","display_name":"Clozapine","level":3,"score":0.5853816866874695},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.5713952779769897},{"id":"https://openalex.org/C2776978879","wikidata":"https://www.wikidata.org/wiki/Q58376","display_name":"Fluphenazine","level":4,"score":0.5613122582435608},{"id":"https://openalex.org/C2780688371","wikidata":"https://www.wikidata.org/wiki/Q58375","display_name":"Thioridazine","level":3,"score":0.553414523601532},{"id":"https://openalex.org/C2779145073","wikidata":"https://www.wikidata.org/wiki/Q58396","display_name":"Imipramine","level":3,"score":0.5476996302604675},{"id":"https://openalex.org/C2778689640","wikidata":"https://www.wikidata.org/wiki/Q113259","display_name":"Anticholinergic","level":2,"score":0.5263180136680603},{"id":"https://openalex.org/C2779406339","wikidata":"https://www.wikidata.org/wiki/Q2991856","display_name":"Trihexyphenidyl","level":2,"score":0.517959475517273},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4545847177505493},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.44127655029296875},{"id":"https://openalex.org/C2780656706","wikidata":"https://www.wikidata.org/wiki/Q417204","display_name":"Levomepromazine","level":4,"score":0.43771904706954956},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.3744220733642578},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.16413667798042297},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.13492467999458313},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.10593605041503906},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001522","descriptor_name":"Behavior, Animal","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D003216","descriptor_name":"Conditioning, Operant","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004644","descriptor_name":"Emotions","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006220","descriptor_name":"Haloperidol","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014282","descriptor_name":"Trihexyphenidyl","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018680","descriptor_name":"Cholinergic Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1007/bf02244927","doi":"https://doi.org/10.1007/bf02244927","is_oa":false,"landing_page_url":"https://doi.org/10.1007/bf02244927","pdf_url":null,"source":{"id":"https://openalex.org/S80334769","display_name":"Psychopharmacology","issn_l":"0033-3158","issn":["0033-3158","1432-2072"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:7871036","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7871036","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2941030096","display_name":"NEURAL SUBSTRATES OF ATTENTION DEFICITS IN SCHIZOPHRENIA","funder_award_id":"R29MH047503","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"},{"id":"https://openalex.org/G8668171492","display_name":"MESOAMYGDALOID DOPAMINE NEURONS AND ANTIPSYCHOTIC DRUGS","funder_award_id":"R01MH039967","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"}],"funders":[{"id":"https://openalex.org/F4320337346","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":62,"referenced_works":["https://openalex.org/W636891040","https://openalex.org/W1582529222","https://openalex.org/W1607600798","https://openalex.org/W1792662730","https://openalex.org/W1968630208","https://openalex.org/W1968753137","https://openalex.org/W1973967548","https://openalex.org/W1975244133","https://openalex.org/W1984486655","https://openalex.org/W1986065821","https://openalex.org/W1986264597","https://openalex.org/W1986775943","https://openalex.org/W1992083518","https://openalex.org/W1993683326","https://openalex.org/W1994186616","https://openalex.org/W1996814400","https://openalex.org/W2000030766","https://openalex.org/W2004118951","https://openalex.org/W2005697734","https://openalex.org/W2006820723","https://openalex.org/W2018463070","https://openalex.org/W2024277205","https://openalex.org/W2032395354","https://openalex.org/W2034091951","https://openalex.org/W2034490011","https://openalex.org/W2037198397","https://openalex.org/W2043937142","https://openalex.org/W2048405858","https://openalex.org/W2049366284","https://openalex.org/W2052294852","https://openalex.org/W2055366180","https://openalex.org/W2058213442","https://openalex.org/W2062903132","https://openalex.org/W2067103214","https://openalex.org/W2071258047","https://openalex.org/W2078108503","https://openalex.org/W2080155490","https://openalex.org/W2084274497","https://openalex.org/W2085360366","https://openalex.org/W2085604849","https://openalex.org/W2087148126","https://openalex.org/W2088445837","https://openalex.org/W2096029767","https://openalex.org/W2099563309","https://openalex.org/W2109865728","https://openalex.org/W2113967506","https://openalex.org/W2117897510","https://openalex.org/W2124181495","https://openalex.org/W2129847975","https://openalex.org/W2157766053","https://openalex.org/W2165695298","https://openalex.org/W2292232883","https://openalex.org/W2319190637","https://openalex.org/W2408232329","https://openalex.org/W2411509200","https://openalex.org/W2413949081","https://openalex.org/W2416010823","https://openalex.org/W3026721701","https://openalex.org/W3028131295","https://openalex.org/W3203633735","https://openalex.org/W4239785504","https://openalex.org/W4299298262"],"related_works":["https://openalex.org/W1986504643","https://openalex.org/W1996814400","https://openalex.org/W1981356959","https://openalex.org/W2061138142","https://openalex.org/W2127217405","https://openalex.org/W2165429333","https://openalex.org/W2014027098","https://openalex.org/W1985379159","https://openalex.org/W1997800912","https://openalex.org/W2033435798"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2087782827","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":4},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
